These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Treatment strategy of Alzheimer's disease: pause in clinical trials of Abeta vaccine and next steps]. Kuzuhara S. Brain Nerve; 2010 Jul; 62(7):659-66. PubMed ID: 20675870 [Abstract] [Full Text] [Related]
12. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Lewis J, Dickson DW, Lin WL, Chisholm L, Corral A, Jones G, Yen SH, Sahara N, Skipper L, Yager D, Eckman C, Hardy J, Hutton M, McGowan E. Science; 2001 Aug 24; 293(5534):1487-91. PubMed ID: 11520987 [Abstract] [Full Text] [Related]
17. Phosphorylation of Tau at S422 is enhanced by Abeta in TauPS2APP triple transgenic mice. Grueninger F, Bohrmann B, Czech C, Ballard TM, Frey JR, Weidensteiner C, von Kienlin M, Ozmen L. Neurobiol Dis; 2010 Feb 24; 37(2):294-306. PubMed ID: 19781645 [Abstract] [Full Text] [Related]
19. Neurofibrillary tangle formation by introducing wild-type human tau into APP transgenic mice. Umeda T, Maekawa S, Kimura T, Takashima A, Tomiyama T, Mori H. Acta Neuropathol; 2014 May 24; 127(5):685-98. PubMed ID: 24531886 [Abstract] [Full Text] [Related]